Thursday, November 14, 2024
HomeIndustriesHealthcare

Healthcare

Harmony Biosciences Announces Plans To Initiate Phase 3 Clinical Trial For Treatment Of Idiopathic Hypersomnia

Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today...

QUOMI Launches An Innovative, Premium, Digital, Community Network For Healthcare Professionals (HCP)

QUOMI as a premium, digital, healthcare community aims at bringing a new order and possibilities for all levels of HCP by disrupting old structures...

Samsung Biologics adds to global ISO certifications with Quality Management System

Samsung Biologics  the world's leading contract development and manufacturing organization, held an award ceremony with the British Standard Institution at its Songdo headquarters for...

UCB Announces Global Partnership To Bring Disease-Modifying Therapies To People Living With Parkinson’s Disease

UCB announced that it has entered into a global co-development and co-commercialization agreement with Novartis covering UCB0599, a potential first in class, small molecule,...

Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies

Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, and Cancer Research UK,...
0FansLike
0FollowersFollow
spot_img

Hot Topics